Marion Merrell Dow: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
Tags: mobile edit mobile web edit
 
Line 1: Line 1:
'''Marion Merrell Dow''' was a leading American pharmaceutical company that played a significant role in the development, manufacturing, and marketing of pharmaceutical products during its time of operation. The company was formed through the merger of Marion Laboratories and Merrell Dow Pharmaceuticals in 1989, creating a powerhouse in the pharmaceutical industry with a broad range of products that addressed various medical conditions and diseases.
{{short description|American pharmaceutical company}}


==History==
== Marion Merrell Dow ==
The origins of Marion Merrell Dow can be traced back to the founding of its predecessor companies, [[Marion Laboratories]] and [[Merrell Dow Pharmaceuticals]]. Marion Laboratories was established in Kansas City, Missouri, by Ewing Marion Kauffman in 1950. It was known for its innovative approach to sales and marketing, as well as for its commitment to research and development. On the other hand, Merrell Dow Pharmaceuticals had its roots in the early 20th century and was recognized for its scientific contributions to medicine, including the development of notable drugs.
[[File:Marion-labs1.jpg|thumb|right|Marion Laboratories headquarters]]
'''Marion Merrell Dow''' was a major [[pharmaceutical company]] in the [[United States]] that played a significant role in the development and marketing of various [[medications]]. The company was known for its innovative approaches in the pharmaceutical industry and its contributions to healthcare.


In 1989, the two companies merged to form Marion Merrell Dow, combining their strengths in research, marketing, and product portfolios. The merger was aimed at creating a more competitive entity capable of achieving greater market penetration and expanding its research capabilities.
== History ==
Marion Merrell Dow was formed through the merger of [[Marion Laboratories]], founded by [[Ewing Marion Kauffman]] in 1950, and [[Merrell Dow Pharmaceuticals]], a subsidiary of [[Dow Chemical Company]]. The merger took place in 1989, creating a significant entity in the pharmaceutical sector.


==Products and Innovations==
=== Marion Laboratories ===
Marion Merrell Dow was responsible for several key pharmaceutical products and innovations. Among its notable contributions was the development of [[Seldane]], a pioneering antihistamine that was among the first to claim non-sedating properties, making it a popular choice for allergy sufferers. However, Seldane was later withdrawn from the market due to safety concerns related to heart arrhythmias when taken with other medications.
[[File:Marion-labs1.jpg|thumb|left|Marion Laboratories building]]
Marion Laboratories was established in [[Kansas City, Missouri]], and quickly grew due to its focus on innovative drug development and marketing strategies. The company was known for its entrepreneurial spirit and strong corporate culture.


Another significant product was [[Cardizem]] (diltiazem), a calcium channel blocker used in the treatment of hypertension and angina. Cardizem became one of the company's best-selling drugs, recognized for its efficacy and safety profile.
=== Merrell Dow Pharmaceuticals ===
Merrell Dow Pharmaceuticals was originally part of the Dow Chemical Company, focusing on the development of prescription drugs. It had a strong presence in the pharmaceutical market before merging with Marion Laboratories.


==Acquisition and Legacy==
== Products ==
The legacy of Marion Merrell Dow continued beyond its existence as an independent company. In 1995, Marion Merrell Dow was acquired by Hoechst AG, a German chemical and pharmaceutical company. This acquisition led to the formation of Hoechst Marion Roussel, which later became part of Sanofi, a global pharmaceutical giant. The acquisition marked the end of Marion Merrell Dow as a standalone entity but its contributions to the pharmaceutical industry, through its products and innovations, have had a lasting impact.
Marion Merrell Dow was known for several key pharmaceutical products, including medications for [[cardiovascular disease]], [[allergies]], and [[central nervous system]] disorders. Some of its well-known products included [[Seldane]] (terfenadine), an antihistamine, and [[Cardizem]] (diltiazem), a drug used to treat hypertension and angina.


==Conclusion==
== Acquisition and Legacy ==
Marion Merrell Dow represents an important chapter in the history of the pharmaceutical industry. Through its innovative products and strategic mergers, the company contributed significantly to the advancement of medical science and the development of drugs that have improved the quality of life for many individuals. Its legacy continues to influence the pharmaceutical sector, underscoring the importance of innovation and strategic collaboration in the advancement of healthcare.
In 1996, Marion Merrell Dow was acquired by [[Hoechst AG]], a German chemical and pharmaceutical company, which later became part of [[Aventis]]. The acquisition marked the end of Marion Merrell Dow as an independent entity, but its legacy continued through the products and innovations it developed.
 
== Related pages ==
* [[Pharmaceutical industry]]
* [[Ewing Marion Kauffman]]
* [[Dow Chemical Company]]
* [[Hoechst AG]]


[[Category:Pharmaceutical companies of the United States]]
[[Category:Pharmaceutical companies of the United States]]
{{pharma-stub}}
[[Category:Defunct companies of the United States]]
[[Category:Companies established in 1989]]
[[Category:Companies disestablished in 1996]]

Latest revision as of 11:32, 15 February 2025

American pharmaceutical company


Marion Merrell Dow[edit]

Marion Laboratories headquarters

Marion Merrell Dow was a major pharmaceutical company in the United States that played a significant role in the development and marketing of various medications. The company was known for its innovative approaches in the pharmaceutical industry and its contributions to healthcare.

History[edit]

Marion Merrell Dow was formed through the merger of Marion Laboratories, founded by Ewing Marion Kauffman in 1950, and Merrell Dow Pharmaceuticals, a subsidiary of Dow Chemical Company. The merger took place in 1989, creating a significant entity in the pharmaceutical sector.

Marion Laboratories[edit]

Marion Laboratories building

Marion Laboratories was established in Kansas City, Missouri, and quickly grew due to its focus on innovative drug development and marketing strategies. The company was known for its entrepreneurial spirit and strong corporate culture.

Merrell Dow Pharmaceuticals[edit]

Merrell Dow Pharmaceuticals was originally part of the Dow Chemical Company, focusing on the development of prescription drugs. It had a strong presence in the pharmaceutical market before merging with Marion Laboratories.

Products[edit]

Marion Merrell Dow was known for several key pharmaceutical products, including medications for cardiovascular disease, allergies, and central nervous system disorders. Some of its well-known products included Seldane (terfenadine), an antihistamine, and Cardizem (diltiazem), a drug used to treat hypertension and angina.

Acquisition and Legacy[edit]

In 1996, Marion Merrell Dow was acquired by Hoechst AG, a German chemical and pharmaceutical company, which later became part of Aventis. The acquisition marked the end of Marion Merrell Dow as an independent entity, but its legacy continued through the products and innovations it developed.

Related pages[edit]